Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle L Turski

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Discovery Medicine|March 1, 2015
Targeted therapy for genetic cancer syndromes: Von Hippel-Lindau disease, Cowden syndrome, and Proteus syndromeRishi Agarwal, Sarah Liebe, Michelle L Turski, et al.
Discovery Medicine|March 1, 2015
Targeted therapy for genetic cancer syndromes: Fanconi anemia, medullary thyroid cancer, tuberous sclerosis, and RASopathiesRishi Agarwal, Sarah Liebe, Michelle L Turski, et al.
Discovery Medicine|January 1, 2015
Targeted therapy for hereditary cancer syndromes: neurofibromatosis type 1, neurofibromatosis type 2, and Gorlin syndromeRishi Agarwal, Sarah Liebe, Michelle L Turski, et al.
Nature|April 11, 2014
Copper is required for oncogenic BRAF signalling and tumorigenesisDonita C Brady, Matthew S Crowe, Michelle L Turski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2026
Efficacy of the ATR inhibitor ceralasertib in patients with ARID1A-deficient gynecologic and other solid tumor malignanciesXiaolin Zhu, Edwin A Alvarez, Sarah E Umetsu, et al.
The Oncologist|June 22, 2024
HER2 overexpression in urothelial carcinoma with GATA3 and PPARG copy number gainsXiaolin Zhu, Emily Chan, Michelle L Turski, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Discovery Medicine|March 1, 2015
Targeted therapy for genetic cancer syndromes: Von Hippel-Lindau disease, Cowden syndrome, and Proteus syndromeRishi Agarwal, Sarah Liebe, Michelle L Turski, et al.
Discovery Medicine|March 1, 2015
Targeted therapy for genetic cancer syndromes: Fanconi anemia, medullary thyroid cancer, tuberous sclerosis, and RASopathiesRishi Agarwal, Sarah Liebe, Michelle L Turski, et al.
Discovery Medicine|January 1, 2015
Targeted therapy for hereditary cancer syndromes: neurofibromatosis type 1, neurofibromatosis type 2, and Gorlin syndromeRishi Agarwal, Sarah Liebe, Michelle L Turski, et al.
Nature|April 11, 2014
Copper is required for oncogenic BRAF signalling and tumorigenesisDonita C Brady, Matthew S Crowe, Michelle L Turski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2026
Efficacy of the ATR inhibitor ceralasertib in patients with ARID1A-deficient gynecologic and other solid tumor malignanciesXiaolin Zhu, Edwin A Alvarez, Sarah E Umetsu, et al.
The Oncologist|June 22, 2024
HER2 overexpression in urothelial carcinoma with GATA3 and PPARG copy number gainsXiaolin Zhu, Emily Chan, Michelle L Turski, et al.
Pageof 2